NRIX vs UPS · rev $54.5M vs P/E 15, rev $88.66B
Nurix Therapeutics Inc (NRIX) versus United Parcel Service Inc (UPS) — a side-by-side from cached financials, not a winner call.
Nurix Therapeutics Inc (NRIX) is a biotechnology company listed on NASDAQ.
United Parcel Service Inc (UPS) is a integrated freight & logistics company listed on US.
Latest reported NRIX revenue for 2024-11-30 was $54.5M. Net income was -$193.6M. Revenue was down 29.1% from 2023-11-30 to 2024-11-30. NRIX currently screens at market cap $1.77B.
Latest reported UPS revenue for 2025-12-31 was $88.66B. Net income was $5.57B. Revenue was down 2.6% from 2024-12-31 to 2025-12-31. UPS currently screens at market cap $85.76B and trailing P/E 14.8.
NRIX currently screens at market cap $1.77B. UPS currently screens at market cap $85.76B and trailing P/E 14.8.
Not investment advice. Open the NRIX and UPS stock pages for the full models.
Not investment advice.